Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Michael

Showing results (821-830 of 1,306) with videos related to

Pageof 131
Sort By:
JACC. Heart Failure|August 18, 2020
In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United StatesStephen J Greene, Taylor S Triana, Raluca Ionescu-Ittu, et al.
Journal of Cardiac Failure|August 17, 2004
The impact of arrhythmias in acute heart failureRaymond L Benza, José A Tallaj, G Michael Felker, et al.
Allergy and Asthma Proceedings|August 18, 2006
Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placeboFrank C Hampel, Paul H Ratner, Niran J Amar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodiesG Michael Iverson, Stephen Reddel, Edward J Victoria, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 27, 2007
An assessment of the onset and duration of action of olopatadine nasal sprayPiyush Patel, Peter S Roland, Bradley F Marple, et al.
ESC Heart Failure|December 24, 2024
Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF)Jan Biegus, JoAnn Lindenfeld, G Michael Felker, et al.
Journal of Neurology|August 16, 2021
Capturing vertigo in the emergency room: three tools to double the rate of diagnosisBenjamin Nham, Nicole Reid, Kendall Bein, et al.
JACC. Heart Failure|April 1, 2022
Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT TrialMuhammad Shahzeb Khan, Matthew W Segar, Muhammad Shariq Usman, et al.
JAMA Cardiology|May 12, 2017
Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX TrialHanghang Wang, Kevin Anstrom, Olga Ilkayeva, et al.
European Journal of Heart Failure|September 18, 2020
Sex-based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanNasrien E Ibrahim, Ileana L Piña, Alexander Camacho, et al.
Pageof 131

Showing results (821-830 of 1,306) with videos related to

Sort By:
Pageof 131
JACC. Heart Failure|August 18, 2020
In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United StatesStephen J Greene, Taylor S Triana, Raluca Ionescu-Ittu, et al.
Journal of Cardiac Failure|August 17, 2004
The impact of arrhythmias in acute heart failureRaymond L Benza, José A Tallaj, G Michael Felker, et al.
Allergy and Asthma Proceedings|August 18, 2006
Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placeboFrank C Hampel, Paul H Ratner, Niran J Amar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2002
Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodiesG Michael Iverson, Stephen Reddel, Edward J Victoria, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 27, 2007
An assessment of the onset and duration of action of olopatadine nasal sprayPiyush Patel, Peter S Roland, Bradley F Marple, et al.
ESC Heart Failure|December 24, 2024
Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA-HF)Jan Biegus, JoAnn Lindenfeld, G Michael Felker, et al.
Journal of Neurology|August 16, 2021
Capturing vertigo in the emergency room: three tools to double the rate of diagnosisBenjamin Nham, Nicole Reid, Kendall Bein, et al.
JACC. Heart Failure|April 1, 2022
Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT TrialMuhammad Shahzeb Khan, Matthew W Segar, Muhammad Shariq Usman, et al.
JAMA Cardiology|May 12, 2017
Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX TrialHanghang Wang, Kevin Anstrom, Olga Ilkayeva, et al.
European Journal of Heart Failure|September 18, 2020
Sex-based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanNasrien E Ibrahim, Ileana L Piña, Alexander Camacho, et al.
Pageof 131